G Á Martos-Moreno1,2, A Mastrangelo3, V Barrios1,2, A García3, J A Chowen1,2, F J Rupérez3, C Barbas3, J Argente1,2,4. 1. Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, Madrid, Spain. 2. Department of Pediatrics, Universidad Autónoma de Madrid, CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain. 3. Centre for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, CEU San Pablo CEU University, Madrid, Spain. 4. IMDEA Food Institute, CEI UAM+CSIC, Madrid, Spain.
Abstract
BACKGROUND/ OBJECTIVES: Insulin resistance (IR) is the cornerstone of the obesity-associated metabolic derangements observed in obese children. Targeted metabolomics was employed to explore the pathophysiological relevance of hyperinsulinemia in childhood obesity in order to identify biomarkers of IR with potential clinical application. SUBJECTS/ METHODS: One hundred prepubertal obese children (50 girls/50 boys, 50% IR and 50% non-IR in each group), underwent an oral glucose tolerance test for usual carbohydrate and lipid metabolism determinations. Fasting serum leptin, total and high molecular weight-adiponectin and high-sensitivity C-reactive protein (CRP) levels were measured and the metabolites showing significant differences between IR and non-IR groups in a previous metabolomics study were quantified. Enrichment of metabolic pathways (quantitative enrichment analysis) and the correlations between lipid and carbohydrate metabolism parameters, adipokines and serum metabolites were investigated, with their discriminatory capacity being evaluated by receiver operating characteristic (ROC) analysis. RESULTS: Twenty-three metabolite sets were enriched in the serum metabolome of IR obese children (P<0.05, false discovery rate (FDR)<5%). The urea cycle, alanine metabolism and glucose-alanine cycle were the most significantly enriched pathways (PFDR<0.00005). The high correlation between metabolites related to fatty acid oxidation and amino acids (mainly branched chain and aromatic amino acids) pointed to the possible contribution of mitochondrial dysfunction in IR. The degree of body mass index-standard deviation score (BMI-SDS) excess did not correlate with any of the metabolomic components studied. In the ROC analysis, the combination of leptin and alanine showed a high IR discrimination value in the whole cohort (area under curve, AUCALL=0.87), as well as in boys (AUCM=0.84) and girls (AUCF=0.91) when considered separately. However, the specific metabolite/adipokine combinations with highest sensitivity were different between the sexes. CONCLUSIONS: Combined sets of metabolic, adipokine and metabolomic parameters can identify pathophysiological relevant IR in a single fasting sample, suggesting a potential application of metabolomic analysis in clinical practice to better identify children at risk without using invasive protocols.
BACKGROUND/ OBJECTIVES:Insulin resistance (IR) is the cornerstone of the obesity-associated metabolic derangements observed in obesechildren. Targeted metabolomics was employed to explore the pathophysiological relevance of hyperinsulinemia in childhood obesity in order to identify biomarkers of IR with potential clinical application. SUBJECTS/ METHODS: One hundred prepubertal obesechildren (50 girls/50 boys, 50% IR and 50% non-IR in each group), underwent an oral glucose tolerance test for usual carbohydrate and lipid metabolism determinations. Fasting serum leptin, total and high molecular weight-adiponectin and high-sensitivity C-reactive protein (CRP) levels were measured and the metabolites showing significant differences between IR and non-IR groups in a previous metabolomics study were quantified. Enrichment of metabolic pathways (quantitative enrichment analysis) and the correlations between lipid and carbohydrate metabolism parameters, adipokines and serum metabolites were investigated, with their discriminatory capacity being evaluated by receiver operating characteristic (ROC) analysis. RESULTS: Twenty-three metabolite sets were enriched in the serum metabolome of IR obesechildren (P<0.05, false discovery rate (FDR)<5%). The urea cycle, alanine metabolism and glucose-alanine cycle were the most significantly enriched pathways (PFDR<0.00005). The high correlation between metabolites related to fatty acid oxidation and amino acids (mainly branched chain and aromatic amino acids) pointed to the possible contribution of mitochondrial dysfunction in IR. The degree of body mass index-standard deviation score (BMI-SDS) excess did not correlate with any of the metabolomic components studied. In the ROC analysis, the combination of leptin and alanine showed a high IR discrimination value in the whole cohort (area under curve, AUCALL=0.87), as well as in boys (AUCM=0.84) and girls (AUCF=0.91) when considered separately. However, the specific metabolite/adipokine combinations with highest sensitivity were different between the sexes. CONCLUSIONS: Combined sets of metabolic, adipokine and metabolomic parameters can identify pathophysiological relevant IR in a single fasting sample, suggesting a potential application of metabolomic analysis in clinical practice to better identify children at risk without using invasive protocols.
Authors: Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio Journal: Cell Metab Date: 2008-01 Impact factor: 27.287
Authors: Christian Hellmuth; Olaf Uhl; Franca F Kirchberg; Veit Grote; Martina Weber; Peter Rzehak; Clotilde Carlier; Natalia Ferre; Elvira Verduci; Dariusz Gruszfeld; Piotr Socha; Berthold Koletzko Journal: Nestle Nutr Inst Workshop Ser Date: 2016-04-18
Authors: Wolfram Goessling; Joseph M Massaro; Ramachandran S Vasan; Ralph B D'Agostino; R Curtis Ellison; Caroline S Fox Journal: Gastroenterology Date: 2008-09-20 Impact factor: 22.682
Authors: Alena Stancáková; Mete Civelek; Niyas K Saleem; Pasi Soininen; Antti J Kangas; Henna Cederberg; Jussi Paananen; Jussi Pihlajamäki; Lori L Bonnycastle; Mario A Morken; Michael Boehnke; Päivi Pajukanta; Aldons J Lusis; Francis S Collins; Johanna Kuusisto; Mika Ala-Korpela; Markku Laakso Journal: Diabetes Date: 2012-05-02 Impact factor: 9.461
Authors: Elisabet Einarsdottir; Minna Pekkinen; Kaarel Krjutškov; Shintaro Katayama; Juha Kere; Outi Mäkitie; Heli Viljakainen Journal: Endocr Connect Date: 2019-05-01 Impact factor: 3.335
Authors: Francisco J Rupérez; Gabriel Á Martos-Moreno; David Chamoso-Sánchez; Coral Barbas; Jesús Argente Journal: Nutrients Date: 2020-10-29 Impact factor: 5.717
Authors: Nikos Stratakis; Alexandros P Siskos; Eleni Papadopoulou; Hector C Keun; Leda Chatzi; Anh N Nguyen; Yinqi Zhao; Katerina Margetaki; Chung-Ho E Lau; Muireann Coen; Lea Maitre; Silvia Fernández-Barrés; Lydiane Agier; Sandra Andrusaityte; Xavier Basagaña; Anne Lise Brantsaeter; Maribel Casas; Serena Fossati; Regina Grazuleviciene; Barbara Heude; Rosemary Rc McEachan; Helle Margrete Meltzer; Christopher Millett; Fernanda Rauber; Oliver Robinson; Theano Roumeliotaki; Eva Borras; Eduard Sabidó; Jose Urquiza; Marina Vafeiadi; Paolo Vineis; Trudy Voortman; John Wright; David V Conti; Martine Vrijheid Journal: Elife Date: 2022-01-25 Impact factor: 8.140
Authors: Margot De Spiegeleer; Ellen De Paepe; Lieven Van Meulebroek; Inge Gies; Jean De Schepper; Lynn Vanhaecke Journal: Mol Med Date: 2021-11-06 Impact factor: 6.354
Authors: Antonio Paride Passaro; Pierluigi Marzuillo; Stefano Guarino; Federica Scaglione; Emanuele Miraglia Del Giudice; Anna Di Sessa Journal: World J Diabetes Date: 2021-12-15